Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07208448

Voll Degradable Shoulder Spacer FIH Study

A Multi-Center, Prospective, First-In-Human Study to Evaluate the Initial Safety and Effectiveness of a Degradable Shoulder Spacer in Patients With Symptomatic Massive Rotator Cuff Tears

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Voll Medical Technologies Ltd. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).

Conditions

Interventions

TypeNameDescription
DEVICEVoll Degradable Shoulder SpacerVoll Degradable Shoulder Spacer

Timeline

Start date
2025-12-09
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2025-10-06
Last updated
2026-03-06

Locations

4 sites across 2 countries: Israel, Italy

Source: ClinicalTrials.gov record NCT07208448. Inclusion in this directory is not an endorsement.